221 related articles for article (PubMed ID: 23248572)
1. Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder.
Yamamoto H; Tsuchida H; Nakamae T; Nishida S; Sakai Y; Fujimori A; Narumoto J; Wada Y; Yoshida T; Taga C; Fukui K
Neuropsychiatr Dis Treat; 2012; 8():579-83. PubMed ID: 23248572
[TBL] [Abstract][Full Text] [Related]
2. Reliability and validity of the Thai self-report version of the Yale-Brown Obsessive-Compulsive Scale-Second Edition.
Hiranyatheb T; Saipanish R; Lotrakul M; Prasertchai R; Ketkaew W; Jullagate S; Udomsubpayakul U; Kusalaruk P
Neuropsychiatr Dis Treat; 2015; 11():2817-24. PubMed ID: 26604766
[TBL] [Abstract][Full Text] [Related]
3. Reliability and validity of the Thai version of the Yale-Brown Obsessive Compulsive Scale - Second Edition in clinical samples.
Hiranyatheb T; Saipanish R; Lotrakul M
Neuropsychiatr Dis Treat; 2014; 10():471-7. PubMed ID: 24648741
[TBL] [Abstract][Full Text] [Related]
4. The impact of personality traits on ratings of obsessive-compulsive symptoms.
Huh MJ; Shim G; Byun MS; Kim SN; Kim E; Jang JH; Shin MS; Kwon JS
Psychiatry Investig; 2013 Sep; 10(3):259-65. PubMed ID: 24302949
[TBL] [Abstract][Full Text] [Related]
5. Further psychometric properties of the Yale-Brown Obsessive Compulsive Scale - Second Edition.
Wu MS; McGuire JF; Horng B; Storch EA
Compr Psychiatry; 2016 Apr; 66():96-103. PubMed ID: 26995242
[TBL] [Abstract][Full Text] [Related]
6. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
[TBL] [Abstract][Full Text] [Related]
7. Effects of the COVID-19 Pandemic on Obsessive-Compulsive Symptoms Among University Students: Prospective Cohort Survey Study.
Ji G; Wei W; Yue KC; Li H; Shi LJ; Ma JD; He CY; Zhou SS; Zhao Z; Lou T; Cheng J; Yang SC; Hu XZ
J Med Internet Res; 2020 Sep; 22(9):e21915. PubMed ID: 32931444
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
[TBL] [Abstract][Full Text] [Related]
9. Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults.
Castro-Rodrigues P; Camacho M; Almeida S; Marinho M; Soares C; Barahona-Corrêa JB; Oliveira-Maia AJ
Front Psychiatry; 2018; 9():431. PubMed ID: 30254588
[No Abstract] [Full Text] [Related]
10. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition.
Storch EA; Rasmussen SA; Price LH; Larson MJ; Murphy TK; Goodman WK
Psychol Assess; 2010 Jun; 22(2):223-32. PubMed ID: 20528050
[TBL] [Abstract][Full Text] [Related]
11. Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.
Askari N; Moin M; Sanati M; Tajdini M; Hosseini SM; Modabbernia A; Najand B; Salimi S; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S
CNS Drugs; 2012 Oct; 26(10):883-92. PubMed ID: 22873680
[TBL] [Abstract][Full Text] [Related]
12. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
13. Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients.
Spatola G; Martinez-Alvarez R; Martínez-Moreno N; Rey G; Linera J; Rios-Lago M; Sanz M; Gutiérrez J; Vidal P; Richieri R; Régis J
J Neurosurg; 2018 Sep; 131(2):376-383. PubMed ID: 30215566
[TBL] [Abstract][Full Text] [Related]
14. Two types of impairments in OCD: obsessions, as problems of thought suppression; compulsions, as behavioral-executive impairment.
Harsányi A; Csigó K; Rajkai C; Demeter G; Németh A; Racsmány M
Psychiatry Res; 2014 Mar; 215(3):651-8. PubMed ID: 24418048
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics of obsessive compulsive disorder associated with high levels of schizotypy.
Brakoulias V; Starcevic V; Berle D; Milicevic D; Hannan A; Viswasam K; Mann K
Aust N Z J Psychiatry; 2014 Sep; 48(9):852-60. PubMed ID: 24740253
[TBL] [Abstract][Full Text] [Related]
16. Defining clinical severity in adults with obsessive-compulsive disorder.
Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
[TBL] [Abstract][Full Text] [Related]
17. Course of obsessive-compulsive disorder during early postpartum period: a prospective analysis of 16 cases.
Uguz F; Gezginc K; Zeytinci IE; Karatayli S; Askin R; Guler O; Sahin FK; Emul HM; Ozbulut O; Gecici O
Compr Psychiatry; 2007; 48(6):558-61. PubMed ID: 17954142
[TBL] [Abstract][Full Text] [Related]
18. The Impact of COVID-19 Pandemic on Obsession and Compulsion Symptoms in Saudi Arabia.
Alhujaili N; Alghamdi A; Abo Talib T; Alhaqbani M; Alfelali M; Alghamdi W
Cureus; 2021 Nov; 13(11):e20021. PubMed ID: 34987909
[TBL] [Abstract][Full Text] [Related]
19. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition.
Zhang CC; Gong H; Zhang Y; Jin H; Yang Y; Li B; Li Y; Luo X; Liu W; Fang F; Li B; Sun B; Fletcher T; La Buissonnière-Ariza V; Goodman WK; Storch EA
Braz J Psychiatry; 2019; 41(6):494-498. PubMed ID: 30785537
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-Compulsive Disorder During the Initial Stage of COVID-19 Pandemic: Effect of Contamination Symptoms and Poor Insight on Obsessive-Compulsive Disorder Exacerbation.
Tulacı RG; Tulacı ÖD; Dolapoğlu N
J Nerv Ment Dis; 2022 Aug; 210(8):570-576. PubMed ID: 35900776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
